Modified COVID-19 vaccines may get nod from FDA without repeating full trials

COVID-19 vaccines adapted for new coronavirus variants can receive authorization from the Food and Drug Administration without repeating full clinical trials.

Source: Los Angeles Times - Science - February 23, 2021 Category: Science Authors: Amina Khan Source Type: news